Rein Therapeutics (RNTX) Accounts Payables (2016 - 2026)
Rein Therapeutics (RNTX) reported Accounts Payables of $4.47 million for Q2 2026, down 25.9% from $6.03 million a year earlier and down 28.7% from the prior quarter.
Powered by 
Analysis
Rein Therapeutics (RNTX) Accounts Payables (2016 - 2026) Analysis & Trends
At the end of FY2025, Rein Therapeutics posted Accounts Payables of $3.98 million, up 336.4% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of 20.0% (FY2020 to FY2025).
- By year, Accounts Payables came in at $911,000 in FY2024 (-23.4%), $1.19 million in FY2023 (-30.8%), $1.72 million in FY2022 (+42.1%) and $1.21 million in FY2021 (-24.2%).
- Five-year quarterly Accounts Payables spans a low of $136,000 in Q2 2023 and a high of $6.26 million in Q1 2026.
- Year over year, Accounts Payables gained in five of the last eight quarters, with growth averaging 220.2%.
- The high point for year-over-year Accounts Payables in five years was Q2 2025 (growth of 670.8%); the low point was Q2 2023 (a decline of 92.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.26 million (Q1 2026), $3.98 million (Q4 2025) and $4.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Rein Therapeutics | 53.67 Mn | 53.67 Mn | - | 4.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.47 Mn |
| Mar 31, 2026 | 6.26 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 6.03 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 911,000.00 |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 782,000.00 |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 484,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Mar 31, 2023 | 458,000.00 |
| Dec 31, 2022 | 1.72 Mn |
| Sep 30, 2022 | 945,000.00 |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 1.21 Mn |
| Sep 30, 2021 | 1.04 Mn |
API Access
Rein Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=RNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();